Crossref
Rethinking the amyloid dogma in Alzheimer’s disease
The Biomedical & Life Sciences Collection · 31.03.2026 · 2026 (3) · e1008434
DOI: 10.69645/tpjr7660 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Biomedical & Life Sciences Collection, online erschienen am 31.03.2026. Verfasst von George Perry.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Perry, G. (2026). Rethinking the amyloid dogma in Alzheimer’s disease. The Biomedical & Life Sciences Collection, 2026(3), e1008434. https://doi.org/10.69645/tpjr7660
Vancouver
Perry G. Rethinking the amyloid dogma in Alzheimer’s disease. The Biomedical & Life Sciences Collection. 2026;2026(3):e1008434. doi:10.69645/tpjr7660
BibTeX
@article{Perry2026,
author = {Perry, George},
title = {Rethinking the amyloid dogma in Alzheimer’s disease},
journal = {The Biomedical & Life Sciences Collection},
year = {2026},
volume = {2026},
number = {3},
pages = {e1008434},
doi = {10.69645/tpjr7660}
}
EUVIMED